IndraLab

Statements

KRAS binds BRAF, TP53, and ALK. 1 / 1

| 1

sparser

"Thirdly, the format of the cSMART assay allows for additional multiplexing and, potentially with careful design, could be expanded to include testing for other oncogenes such as KRAS, BRAF, TP53 and A[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

27071701

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

KRAS binds BRAF, TP53, and ALK. 1 / 1

INDRA sources:

Databases

Reading